Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - LA JOLLA PHARMACEUTICAL CO | c99163e10vk.htm |
| EX-32.1 - EXHIBIT 32.1 - LA JOLLA PHARMACEUTICAL CO | c99163exv32w1.htm |
| EX-31.1 - EXHIBIT 31.1 - LA JOLLA PHARMACEUTICAL CO | c99163exv31w1.htm |
| EX-21.1 - EXHIBIT 21.1 - LA JOLLA PHARMACEUTICAL CO | c99163exv21w1.htm |
| EX-31.2 - EXHIBIT 31.2 - LA JOLLA PHARMACEUTICAL CO | c99163exv31w2.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8
Nos. 333-106060, 333-116233, 333-131248, 333-125427, 333-143677 and 333-151825, Form S-3 Nos.
333-101499, 333-31142, 333-43066, 333-55370, 333-81432, 333-131246, 333-145009 and 333-158750 and
Form S-4 No. 333-163911) of La Jolla Pharmaceutical Company and in the related Prospectus of our
report dated April 15, 2010, with respect to the consolidated financial statements of La Jolla
Pharmaceutical Company, included in this Annual Report (Form 10-K) for the year ended December 31,
2009.
| /s/ Ernst & Young LLP
|
||||
San Diego, California April 15, 2010 |